Themis Medicare Limited has informed the Exchange about General Updates
THEMISMED · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Themis Medicare's Preferential Issue Committee met on 10th March 2026 and revised the issue price of Convertible Equity Warrants from Rs. 100 to Rs. 102.87 per warrant, based on a pricing certificate from a practicing company secretary under SEBI ICDR Regulations. The warrants are proposed to be issued to Vividhmargi Investments Private Limited (a single investor) via preferential allotment, covering up to 4.99% of total shareholding (equivalent to 45,95,795 equity shares). A corrigendum to the Postal Ballot Notice dated 25th February 2026 was also approved. The allotment remains subject to shareholder and stock exchange (BSE/NSE) approvals.
The minor upward revision in warrant price is regulatory-driven (floor price recalculation) and unlikely to materially impact existing shareholders. However, the preferential issue to a specific investor (Vividhmargi Investments) will result in dilution of up to ~5% once warrants are converted, which may be a mild overhang on the stock.